Published on Tue Jul 27 2021

Ribosomal protein L23 drives the metastasis of hepatocellular carcinoma via upregulating MMP9

Chen, J., Li, F., Yang, M., Zhou, Y., Deng, H., Zhou, H., Cheng, S., Zhang, D., He, X., Mai, L., Chen, Y.

RNA binding protein L23 (RPL23) as a tumor metastasis driver in HCC. RPL23 depletion inhibited HCC cell proliferation, migration and invasion. R PL23 overexpression promoted HCC Cell metastasis.

1
0
3
Abstract

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths globally and tumor metastasis is one of the major causes of high mortality. To identify novel molecules contributing to HCC metastasis is critical to understanding the underlining mechanism of cancer metastasis. Here, combining the analyze based on published database and liver tissues from HCC patients, we identified that RNA binding protein L23 (RPL23) as a tumor metastasis driver in HCC. RPL23 was elevated in HCC and closely related to poor clinical outcomes. Furthermore, RPL23 depletion inhibited HCC cell proliferation, migration and invasion, while RPL23 overexpression promoted HCC cell metastasis. Mechanistically, RPL23 positively regulated MMP9 expression by stabilizing its mRNA. And increased MMP9 is involved in RPL23-mediated HCC metastasis. Importantly, RPL23 silencing reduced tumor growth and metastasis in vivo. In summary, we identified that RPL23 play an important role in HCC metastasis in an MMP9-dependent manner and may be a novel potential therapeutic target for HCC tumorigenesis and metastasis.